SCHEMBL8274740

SCHEMBL8274740

CC(=O)O[C@@H](C(=O)NCC1CCN(c2ccc(F)cc2N)CC1)[C@@H](OC(C)=O)C(=O)N1Cc2cnn(C)c2C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HDAC3 O15379 3/20 0.33
▸ HDAC1 Q13547 3/20 0.33
▸ HDAC2 Q92769 3/20 0.33
▸ PDE6D O43924 1/20 0.33
▸ HRAS P01112 1/20 0.33
▸ KRAS P01116 1/20 0.33
▸ DGAT2 Q96PD7 1/20 0.32
▸ RPS6KB1 P23443 2/20 0.32
▸ GAK O14976 1/20 0.31
▸ RORC P51449 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ HTR4 Q13639 1/20 0.31
▸ PIM1 P11309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8221812 0.90 CHRM4 (0.38) HPGDSDGAT2RPS6KB1
SCHEMBL14452908 0.90 CHRM4 (0.38) HPGDSDGAT2RPS6KB1
SCHEMBL8273768 0.87 HPGDS (0.38) HPGDSALDH1A1L3MBTL1HDAC3HDAC1
SCHEMBL8275469 0.79 ADAM17 (0.36) HPGDSALDH1A1HDAC1HDAC2DGAT2
SCHEMBL8217550 0.77 ADAM17 (0.44) HPGDSRPS6KB1
SCHEMBL14452920 0.76 CHRM4 (0.41) DPP8DPP9
SCHEMBL8221551 0.76 CHRM4 (0.41) DPP8DPP9
SCHEMBL8276118 0.73 ADAM17 (0.43) ALDH1A1L3MBTL1DPP8DPP9DPP7
SCHEMBL8274407 0.73 ADAM17 (0.43) ALDH1A1L3MBTL1DPP8DPP9DPP7
SCHEMBL8275285 0.72 NAMPT (0.42) HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005121130-A2 CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2005-12-22 — — WO disclosed
Send feedback